JPRN-UMIN000006096已完成未知
Analysis of Rho-associated kinase(ROCK) activity in human placenta and peripheral blood monocytes. - Analysis of Rho-associated kinase(ROCK) activity in human placenta and peripheral blood monocyte.
Department of obstetrics and gynecology,Hiroshima university of biomedical science0 个研究点目标入组 200 人开始时间: 2011年9月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 45years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •Subjects without informed consent
研究者
相似试验
招募中
不适用
Analysis of Rho kinase (ROCK) activity in subjects with cerebrocardiovascular risk factorHypertension, Diabetes mellitus, Hyperlipidemia, Cigarette smoking, Coronary heart disease, Cerebrovascular disease, Peripheral artery disease, ArteriosclerosisJPRN-UMIN000001167Department of cardiovascular physiology and medicine, Hiroshima university graduate school of biomedical science1,000
已完成
不适用
The effect of Rho kinase inhibitor for the treatment of corneal endothelial dysfunction: the 2nd stepCorneal endothelial dysfunctionJPRN-UMIN000003625Department of Ophthalmology, Kyoto Prefectural University of Medicine20
已完成
2 期
Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALSAmyotrophic lateral sclerosis (ALS)G12.2Motor neuron diseaseDRKS00013948Georg-August-Universität Göttingen, Stiftung Öffentlichen Rechts, Universitätsmedizin Göttingen120
进行中（未招募）
1 期
Inhibition of Rho Kinase (ROCK) with Fasudil as disease-modifying treatment for ALSAmyotrophic lateral sclerosisMedDRA version: 21.1Level: PTClassification code 10002026Term: Amyotrophic lateral sclerosisSystem Organ Class: 10029205 - Nervous system disordersEUCTR2017-003676-31-FRGeorg-August-Universität Göttingen120
已完成
不适用
The effect of Rho kinase inhibitor for the prevention of post-keratoplasty corneal endothelial cell lossPost-keratoplasty corneal endothelial cell lossJPRN-UMIN000007082Department of Ophthalmology, Kyoto Prefectural University of Medicine10